Source: International Congress 2014 – Predictors
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. Vitsas, M. Kardara, A. Koutsoukou, P. Michalopoulou, S. Orfanos, G. Tsoukalas, A. Kotanidou (Athens, Greece). Biomarkers in COPD exacerbation, the role of adiponectin. Eur Respir J 2014; 44: Suppl. 58, 3615

Member's Comments

No comment yet.

Related content which might interest you: Role of inflammatory biomarkers in COPD Source: International Congress 2016 – Systemic biomarkers Year: 2016 Features of systemic inflammation in patients with stable COPD Source: International Congress 2014 – COPD: points to ponder Year: 2014 Prevalence of exacerbation in COPD patients with chronic bronchitis and association with elevated serum inflammatory biomarkers Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Inflammatory markers and COPD phenotypes as predictors of COPD exacerbations Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 Neutrophil CD 64 expression as a diagnostic marker of pneumonia in patients with acute COPD exacerbation Source: International Congress 2014 – Markers Year: 2014 Can red blood cell morphology be an indicator for COPD exacerbations? Source: International Congress 2014 – Markers Year: 2014 Mukoregulatory drugs in treating COPD Source: International Congress 2014 – Predictors Year: 2014 The role of COPD in development of osteoporosis Source: International Congress 2014 – Markers Year: 2014 Role of activated complement in COPD exacerbation recovery Source: International Congress 2014 – Comorbidities Year: 2014 BNP level in patients with COPD exacerbations Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Impact of frequent exacerbations in patients with COPD Source: International Congress 2014 – Clinical presentations Year: 2014 Cells biomarkers of bronchial brush-biopsies at COPD exacerbation Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system Year: 2013 Circulating copeptin is associated with mortality irrespectively of exacerbation rate in stable COPD Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities Year: 2014 Blood eosinophil guided prednisolone therapy for exacerbations of COPD: A further analysis Source: International Congress 2014 – COPD exacerbations Year: 2014 What is the best biomarker of COPD stability? Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Endothelial dysfunction and systemic inflammation in different COPD phenotypes Source: International Congress 2014 – COPD physiopathology Year: 2014 Assessment of malondialdehyde in the airways during treatment of COPD exacerbations Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Exacerbations in patients with chronic obstructive lung disease (COPD) and concomitant asthma Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014 Monitoring catalase activity in COPD exacerbations Source: International Congress 2016 – Airway biomarkers Year: 2016 Blood eosinophils and outcomes in COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016